Vanda receives FDA rejection, issues fiery response against ‘conclusory’ refusal

[cafead]

via Vanda Pharmaceuticals has failed to persuade the FDA to approve its gastroparesis candidate on the strength of a phase 3 trial that missed its primary endpoint. The biotech came out swinging after the knock-back, accusing the agency of sending a complete response letter that generally disregarded the evidence.

article source

 

[anonymous]

Maybe Vanda can bring back Rapella since he knows how to falsify records.